IMMU-14. ONCOLYTIC ADENOVIRUS DELTA-24-RGD ENGINEERED TO EXPRESS 4-1BBL AS A THERAPEUTIC APPROACH FOR DIPG

Despite the advances in our understanding of pediatric diffuse midline gliomas (DMG) they remain the leading cause of pediatric death caused by cancer. Our group has demonstrated that the administration of Delta-24-RGD in DIPG models is safe and therapeutically efficacious. An on-going clinical tria...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Neuro Oncol
Asıl Yazarlar: Laspidea, Virginia, Puigdelloses, Montserrat, Martinez-Velez, Naiara, Garcia-Moure, Marc, Labiano, Sara, Ausejo, Iker, Patiño-García, Ana, Becher, Oren J, Jiang, Hong, Gupta, Sumit, Fueyo, Juan, Gomez-Manzano, Candelaria, M Alonso, Marta
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2020
Konular:
Immunology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7651280/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.444
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller